George D - Search Results

1

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.

D'Amico AV, Saegaert T, Chen MH, Renshaw AA, George D, Oh W, Kantoff PW. D'Amico AV, et al. Among authors: george d. Cancer. 2002 Jul 15;95(2):275-80. doi: 10.1002/cncr.10673. Cancer. 2002. PMID: 12124826 Free article.

2

Prognostic indicators in hormone refractory prostate cancer.

George DJ, Kantoff PW. George DJ, et al. Urol Clin North Am. 1999 May;26(2):303-10, viii. doi: 10.1016/s0094-0143(05)70070-7. Urol Clin North Am. 1999. PMID: 10361553 Review.

3

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.

Kelly WK, Curley T, Slovin S, Heller G, McCaffrey J, Bajorin D, Ciolino A, Regan K, Schwartz M, Kantoff P, George D, Oh W, Smith M, Kaufman D, Small EJ, Schwartz L, Larson S, Tong W, Scher H. Kelly WK, et al. Among authors: george d. J Clin Oncol. 2001 Jan 1;19(1):44-53. doi: 10.1200/JCO.2001.19.1.44. J Clin Oncol. 2001. PMID: 11134194 Clinical Trial.

4

Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer.

Oh WK, George DJ, Hackmann K, Manola J, Kantoff PW. Oh WK, et al. Among authors: george dj. Urology. 2001 Jan;57(1):122-6. doi: 10.1016/s0090-4295(00)00986-9. Urology. 2001. PMID: 11164156

5

PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.

George DJ, Shepard TF, Ma J, Giovannucci E, Kantoff PW, Stampfer MJ. George DJ, et al. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):411-2. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11319185 No abstract available.

6

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW; Cancer and Leukemia Group B 9480. George DJ, et al. Clin Cancer Res. 2001 Jul;7(7):1932-6. Clin Cancer Res. 2001. PMID: 11448906

7

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report.

Oh WK, George DJ, Kaufman DS, Moss K, Smith MR, Richie JP, Kantoff PW. Oh WK, et al. Among authors: george dj. Semin Oncol. 2001 Aug;28(4 Suppl 15):40-4. doi: 10.1016/s0093-7754(01)90153-8. Semin Oncol. 2001. PMID: 11685727 Clinical Trial.

8

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.

Smith MR, Kaufman D, George D, Oh WK, Kazanis M, Manola J, Kantoff PW. Smith MR, et al. Among authors: george d. Cancer. 2002 Nov 1;95(9):1864-8. doi: 10.1002/cncr.10844. Cancer. 2002. PMID: 12404279 Free article. Clinical Trial.

9

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.

Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK. Tay MH, et al. Among authors: george dj. Ann Oncol. 2004 Jun;15(6):974-8. doi: 10.1093/annonc/mdh221. Ann Oncol. 2004. PMID: 15151957 Free article.

10

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy.

Smith MR, Manola J, Kaufman DS, George D, Oh WK, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff PW. Smith MR, et al. Among authors: george d. Cancer. 2004 Oct 1;101(7):1569-74. doi: 10.1002/cncr.20493. Cancer. 2004. PMID: 15468186 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,769 results

Search Page

Filters